295 related articles for article (PubMed ID: 25456832)
1. Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia.
Al-Ahmady ZS; Chaloin O; Kostarelos K
J Control Release; 2014 Dec; 196():332-43. PubMed ID: 25456832
[TBL] [Abstract][Full Text] [Related]
2. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
5. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
6. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
7. Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes.
Al-Jamal WT; Kostarelos K
Nanotheranostics; 2022; 6(3):230-242. PubMed ID: 35145834
[TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.
Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA
Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516
[TBL] [Abstract][Full Text] [Related]
10. Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes.
Al-Ahmady ZS; Hadjidemetriou M; Gubbins J; Kostarelos K
J Control Release; 2018 Apr; 276():157-167. PubMed ID: 29522832
[TBL] [Abstract][Full Text] [Related]
11. Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.
Li M; Li Z; Yang Y; Wang Z; Yang Z; Li B; Xie X; Song J; Zhang H; Li Y; Gao G; Yang J; Mei X; Gong W
Pharm Res; 2016 Aug; 33(8):1881-98. PubMed ID: 27075873
[TBL] [Abstract][Full Text] [Related]
12. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
[TBL] [Abstract][Full Text] [Related]
13. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
14. Gold cluster-labeled thermosensitive liposmes enhance triggered drug release in the tumor microenvironment by a photothermal effect.
Kwon HJ; Byeon Y; Jeon HN; Cho SH; Han HD; Shin BC
J Control Release; 2015 Oct; 216():132-9. PubMed ID: 26247553
[TBL] [Abstract][Full Text] [Related]
15. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
17. A systematic study of temperature sensitive liposomal delivery of doxorubicin using a mathematical model.
Liu C; Xu XY
Comput Biol Med; 2015 May; 60():107-16. PubMed ID: 25817532
[TBL] [Abstract][Full Text] [Related]
18. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.
Hijnen N; Kneepkens E; de Smet M; Langereis S; Heijman E; Grüll H
Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4802-E4811. PubMed ID: 28566498
[TBL] [Abstract][Full Text] [Related]
19. EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery.
Haeri A; Zalba S; Ten Hagen TL; Dadashzadeh S; Koning GA
Colloids Surf B Biointerfaces; 2016 Oct; 146():657-69. PubMed ID: 27434152
[TBL] [Abstract][Full Text] [Related]
20. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]